Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
He can have his opinion.
I haven't read many of the posts, may not be up to speed. I see no reason why we would not see a filing in the next couple days. Would be extremely disappointed if the company delays further.
Saliva test ramp up, would start to see any major revenue in the March filing.
Have my chair setup and popcorn at the ready. Eyes on March, but agree... will be fun to watch what happens between now and then.
Nice to be waking from hibernation.. going to be a lovely spring.
But the good news is longs now get to sit back and watch this slowly but surely creep back up... until.. I'm thinking March. Financials always win.
So the argument is PRED sucks just because. Got it. How dare we compare their practices to legitimate companies who are doing the same thing.
Tons of development stage companies all over the exchanges. Even large profitable companies rely on loans to boost their cash positions to best operate.
That's like asking what business-men borrow to stay business-men.
https://financialpost.com/personal-finance/high-net-worth/elon-musk-short-on-cash-keeps-borrowing-more-and-more-money-even-as-tesla-stock-surges
I remember being extremely frustrated that I got gun shy at buying when we hit our previous low of 0.25 a couple years ago... time to reverse that mistake.
Don't think we'll jump up in price immediately.. but the wave is coming. Tough part will be getting shares soon. My bet is long hands have accumulated much of this and the real tradable float is small.
Starting to seem like lots of money will be made by those getting in ahead of March financials... hope all can average down.
Great update. So looks like they're running saliva tests.. at minimum the Thermo TaqPath assay...
Absurdly wrong that you think any loan would qualify, but if you disagree - please feel free to contact the SEC and have them ignore you.
You're deflecting off the current and only news we've gotten in months, which gives some key insights into the state of present and past business.
Amazing to watch people try to spin this negatively.
Last July being this July... which isn't an 8K required filing. Nice try.
But yeah, a Nasdaq company loaning $3M has no idea what they're doing.
Please educate us investors with no inside connections or info, as I assume there are no leaks and no one here is privy to anything valuable.. so anything could be shared.
What other than the big guy or fabled calvary would a merger with ELGL provide? Seems like the worst decision IMO and I seriously hope it's not being entertained.
Ferguson is too abrasive and outspoken IMO, but I'm not a fan of the ELGL holdings nor their compatibility w/ PRED's portfolio. I'd probably move on if that were the case.
Eh, I'm not expecting much.. but just them filing and on-time is enough. At this point, revenue is what I'm looking for. Looking forward to the December and March Filings, where any testing should be seen.
Piper/Waitn, in all respect.. people do buy/sell based upon sentiment from this board. Posting negatively continuously is only going to cause long investors to tire more... and in turn be more likely to sell.
Normally a stock is buffered from retail volume, but these days we're trading at quantities that just one of us selling could be a big impact.. which then causes more posts and selling.
I get the frustrations, but why do harm to your own investment? Not saying we don't criticize.. just not seeing the benefit in the "they're going bankrupt" posts.
Executives commonly take photos with a golden shovel in a groundbreaking ceremony.. doesn't mean the actual ground breaking is fake.
I keep seeing people reiterate fake photos... what was fake about them?
They did not provide context, but at the time an uplist to Nasdaq did appear imminent and in the cards. I would argue it was more likely that they were there apart of early uplist discussions rather than being there with another group and taking a photo op.
Professional? Debatable. Go look at Elon Musk and how he handles PR with his $400B company if we want to talk professional.
And any mention of photoshop is ridiculous.
Tough to accurately gauge, especially w/ likely competition in the space.. I'd think... ~0.5-1B conservatively/discounted.
Stem Cells
The big guy can have his own opinions. I also don't, nor have ever, held much value in the SCs other than a short term source of revenue.
$20-35 (w/ Nasdaq) IMO was a possibility prior to HB. Biotechs in early development stages can command such a valuation, especially considering PRED's potential in their database and pipeline.
We now have a long uphill battle here... optics alone are not great with the greys/etc, and PRED has made missteps.. but it's a tough time for all companies. I have a lot of confidence we'll find ourselves back at $1-3 minimum, but who knows how long at this point.
Back to hibernation. Good luck to the longs... hope we keep our sanity while we wait.
In fairness, I am not expecting anything on the Saliva tests with the 10K. The first mentions we saw of that possibility were at the end of June.. very unlikely they immediately commercialized. Would expect something in the next Q.
More than frustrating times, but I'm thinking our EOY or filing next march will start to give us some positive traction.
And no... to those posting earlier, I am not selling. Picked up a some cheap shares a couple weeks ago at 0.25 in full truthfulness.
If Deloitte still performs the audit, will be very positive.
Nice post.. good to see some balanced reasoning.
Ah, but he forgot the age old saying:
"When you have runny sauce, toss some beans in the bitch."
Depends on the menu rotation IMO, the current nacho box is one hell of a deal (especially w/ red sauce add-on).
...just like PRED. Hell of a deal. Wish Brad spent more time at TB to reinforce the message.
All this talk on Jennings/etc.. when what we should really be talking about is Chipotle. I know for a fact Brad visits his local one at least once a week. Talk about influence.. those employees are distracting him with all that burrito nonsense.
10-K not yet due.... 2019 Filings for ref:
10-Q: 5/20/2019
10-K: 9/30/2019
10-K is the yearly filing which is 90 days+ fiscal year end (6/30).
Once I can travel across the border, offer is still out there to grab that dinner on my tab.
Up ~20x so far from our yearly low. Seems like party/beer time to me. Lol
Lets start here.
NOTE 14 RELIANCE ON THIRD PARTY VALUATIONS
The Company has relied on third party valuations to determine if an impairment should be recorded and
other purposes as of March 31, 2018.
Equity Method Investments – Lifecode Genetics, Inc.
The third-party valuator, using cash flow projections under various assumptions and after considering
discounts for marketability and minority interests, concluded the fair market value of Juneau
Biosciences, LLC to be approximately $1,320,000,000.
At March 31, 2018 the Company (including
affiliates) owned approximately 49% of Juneau (See note 7), which would value this investment at
approximately $646,800,000.
PREDICTIVE TECHNOLOGY GROUP, INC.
- 24 -
Trade Secrets – Predictive Biotech, Inc.
The third-party valuator, using cash flow projections under various assumptions and after considering
discounts for venture capital, concluded the fair market value of trade secrets acquired with Renovo to
be approximately $501,000,000.
Other Patents and Technologies – Patents regarding Degenerative Disc Disease
Patents were acquired by the issuance of Predictive Therapeutics Class A units as described in note 6.
The third-party valuator, using cash flow projections under various assumptions and after considering
discounts for venture capital, concluded the fair market value of such patents acquired to be
approximately $246,000,000.
I called under the precedent that I was looking at potentially purchasing a large volume of tests on behalf of a specific corporation (assuming the EUA was released for public and private use). I gave real info about myself, which I noticed they also seemed to have looked at my public profile to verify.
That said, the callback was from someone directly involved with sales. He gave general info about two test manufacturers they were working with and the EUA status/details. Noted one company producing out of CN was being put through the ringer, but they expected everything to be cleared up shortly and were still very engaged (which the concern on the board was that they weren't).
Timeline obviously off, but didn't seem to be layered with normal sales BS which I'm used to. My main takeaway was his confidence in the companies they were working with (one had EUA already - US based, not PRED. And PRED), which also seemed very genuine as he detailed some of the current struggles and environment. Also noted immense demand.
I didn't expect to hear back again until EUA given my angle.
With demand increasing and the FDA being behind the 8-ball, we'll see. PRED has also now performed their own (as well as the NCI) validation. I could see them being more open to selling tests without the EUA, whereas previously they only had dablood data. Risk here is recall if independant testing showed the tests didnt perform, but we should be past that.
But who knows. They also have a CLIA lab, and could also pump out other tests if needed during this time.
I understand the SEC's suspension, since the perception was that they didn't have the ability to export tests and the public responses to hindenburg didnt accurately clarify. I believe they did have the ability (later shown with approval docs), but got into a hold waiting for EUA in an ever changing environment with the FDA.
Now there's a rumor on tests arriving, we'll see - but would not be surprised either way. Appears the FDA is gun-shy on EUAs and with test demand increasing Im sure there are many more knocking.
That said, we'd be no where if they didn't put their feet into the COVID water, since other revenue and development streams have taken a large hit.
One additional serology EUA was added Tuesday (Babson - Igg, CLIA Lab only):
https://www.fda.gov/medical-devices/coronavirus-disease-2019-covid-19-emergency-use-authorizations-medical-devices/vitro-diagnostics-euas#individual-serological